LumiraDx gets approval for its COVID-19 Antigen Test in India
Diagnostics testing company LumiraDx has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in...
Sandoz ships first medicine in partnership with Civica Rx to United States hospitals
Sandoz Inc said it has pantoprazole sodium for injection, 40 mg to Civica Rx to supply hospitals in the United States it serves. This...
Research on preventative nasal spray reveals interesting results
Research on a 'novel' nasal spray therapy, INNA-051, which has been shown to reduce Covid-19 viral replication by up to 96 percent in a...
BAT moves Covid candidate vaccine towards Phase I human clinical trials
BAT has announced plans to commence a Phase I first-time-in-human study of its Covid-19 vaccine candidate.
The announcement by BAT's US Bio-tech arm, Kentucky BioProcessing...
AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol: Ionis
Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233).
It is an investigational antisense medicine designed...
Aster Labs unveils Digital Pathology Solution approved by USFDA
Aster Labs has introduced US FDA approved digital pathology solution at two of its facilities.
The diagnostics arm of Aster DM Healthcare, a healthcare service...
Pfizer, Biontech announce vaccine candidate against Covid-19
Pfizer Inc and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against Covid-19 in participants without...
Bharat Biotech’s Odisha facility to make 10 types of vaccines including for Covid-19, Malaria
Bharat Biotech International Ltd (BBIL), a Hyderabad based pharma major, has said it would manufacture 10 types of vaccines. These would be produced in...
Piramal Pharma Solutions on expansion mode, invests ~$32 Million
Piramal Pharma Solutions, a Piramal Pharma Limited business and a leading Contract Development and Manufacturing Organization (CDMO), has revealed its plans to expand its...
Sputnik V vaccine’s efficacy confirmed at 91.4%
Sputnik V, the Russian Covid-19 vaccine, has passed a crucial test. Its efficacy has been confirmed at 91.4 per cent bsed on data analysis...
